Editor-in-chief
Maria Stella Graziani

Deputy Director
Martina Zaninotto

Associate Editors
Ferruccio Ceriotti
Davide Giavarina
Bruna Lo Sasso
Giampaolo Merlini
Martina Montagnana
Andrea Mosca
Paola Pezzati
Rossella Tomaiuolo
Matteo Vidali

International Advisory Board Khosrow Adeli Canada
Sergio Bernardini Italy
Marcello Ciaccio Italy
Eleftherios Diamandis Canada
Philippe Gillery France
Kjell Grankvist Sweden
Hans Jacobs The Netherlands
Eric Kilpatrick UK
Magdalena Krintus Poland
Giuseppe Lippi Italy
☩Howard Morris Australia
Mario Plebani Italy
Sverre Sandberg Norway
Ana-Maria Simundic Croatia
☩Jill Tate Australia
Tommaso Trenti Italy
Cas Weykamp The Netherlands
Maria Willrich USA
Paul Yip Canada


Publisher
Biomedia srl
Via L. Temolo 4, 20126 Milano

Responsible Editor
Giuseppe Agosta

Editorial Secretary
Arianna Lucini Paioni
Biomedia srl
Via L. Temolo 4, 20126 Milano
Tel. 0245498282
email: biochimica.clinica@sibioc.it



Area soci
Non possiedi o non ricordi la password!
Clicca qui

BC: Articoli scritti da A. Posadinu

Interleuchine e necrolisi tossica epidermica
Interleukins and toxic epidermal necrolysis (TEN)
V. Ventura  |  A. Posadinu  |  M. Deiana  |  A. Baralla  |  S. Pasella  |  L. Murgia  |  S. Pinna  |  E.  Canu  |  A. Marchisio  |  A. Zinellu  |  C. Carru  |  L. Deiana  | 
<p>TEN is a rare disease characterized by the separation of skin&nbsp;and mucous membranes from the derma. The reported clinical case refers to an adult female hospitalized at the&nbsp;Burns Unit after allopurinol prescription. During hospitalization the patient underwent the therapeutic protocol&nbsp;established at the Burns Unit including intravenus immunoglobulin administration and plasmapheresis. At the end of&nbsp;therapy a clinical improvement of both local and global conditions was observed. During the course of disease, we&nbsp;measured plasma concentrations of a number of cytokines. Measurements were performed using commercially&nbsp;available multiplex bead-based sandwich immunoassays (Biorad). We found a marked decrease in concentrations of&nbsp;interleukin (IL)-6, interferon -induced protein (IP)-10 e IL-13 at various stages of apheresis therapy, particularly&nbsp;pronounced for IP-10. We also found a normalization of IL-6 and IP-10 concentrations during the follow-up. In&nbsp;addition, very high concentrations of the same cytokines in the plasma effluent after apheresis were observed.&nbsp;Although obtained in a single case, our results suggest a correlation between plasma concentrations of cytokines and&nbsp;the clinical course of TEN. It can be postulated that this approach could serve as a guide for future research in the&nbsp;development of targeted therapy based on the etiopathogenesis of TEN.</p>
Biochimica Clinica ; 38(1) 65-69
Casi clinici - Case report